Displaying drugs 8051 - 8075 of 9934 in total
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL
Experimental
Matched Name: … TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL …
Matched Iupac: … (2S)-2-amino-3-[7-hydroxy-6-(2-phenylhydrazin-1-yl)-1H-indol-3-yl]propanal …
Matched Iupac: … (2S)-2-amino-3-[7-hydroxy-6-(2-phenylhydrazin-1-yl)-1H-indol-3-yl]propanal …
3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE
Experimental
Matched Name: … 3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE …
Matched Iupac: … 3-(2-amino-6-benzoyl-3,4-dihydroquinazolin-3-yl)-N-cyclohexyl-N-methylpropanamide …
Matched Iupac: … 3-(2-amino-6-benzoyl-3,4-dihydroquinazolin-3-yl)-N-cyclohexyl-N-methylpropanamide …
AQ-13 free base
Investigational
Matched Iupac: … 7-chloro-N-[3-(diethylamino)propyl]quinolin-4-amine …
Lerociclib
Lerociclib is under investigation in clinical trial NCT02983071 (G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-positive, Her2-negative Locally Advanced or Metastatic Breast Cancer).
Investigational
Matched Iupac: … 12'-({5-[4-(propan-2-yl)piperazin-1-yl]pyridin-2-yl}amino)-2',5',11',13'-tetraazaspiro[cyclohexane-1,3 …
ABO-201
Investigational
Icotinib
Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)
Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the...
Experimental
Investigational
Matched Iupac: … N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine …
FG-2216
A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability.
Investigational
Matched Synonyms: … (((1-Chloro-4-hydroxyisoquinolin-3-yl)carbonyl)amino)acetic acid ... 1-Chloro-N- (hydroxyformylmethyl-4-hydroxyisoquinoline-3-carboxamide ... 1-Chloro-N-(hydroxyformylmethyl-4-hydroxyisoquinoline-3-carboxamide …
Matched Iupac: … 2-[(1-chloro-4-hydroxyisoquinolin-3-yl)formamido]acetic acid …
Matched Iupac: … 2-[(1-chloro-4-hydroxyisoquinolin-3-yl)formamido]acetic acid …
Esatenolol
Esatenolol is a beta blocker.
Experimental
Matched Synonyms: … S-(-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide ... (S)-4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide ... 2-(p-((2S)-2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide …
Matched Iupac: … 2-{4-[(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy]phenyl}acetamide …
Matched Iupac: … 2-{4-[(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy]phenyl}acetamide …
PEN-866
PEN-866 is under investigation in clinical trial NCT03221400 (PEN-866 in Patients With Advanced Solid Malignancies).
Investigational
Matched Iupac: … {3-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-4-yl}-1H-indol-1-yl)ethyl ... diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl 4-[2-(5- …
Ulinastatin
Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
Investigational
PBCAR20A
Investigational
Buthionine sulfoximine
Buthionine sulfoximine has been used in trials studying the treatment of Neuroblastoma and Melanoma (Skin).
Investigational
Matched Synonyms: … DL-buthionine-(S,R)-sulfoximine …
N-(3-MERCAPTOPROPANOYL)-D-ALANINE
Experimental
Matched Name: … N-(3-MERCAPTOPROPANOYL)-D-ALANINE …
Matched Iupac: … (2R)-2-(3-sulfanylpropanamido)propanoic acid …
Matched Iupac: … (2R)-2-(3-sulfanylpropanamido)propanoic acid …
3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate
Experimental
Matched Name: … 3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate …
Matched Iupac: … N-(7-carbamimidoylnaphthalen-1-yl)-3-[(3-hydroxypropoxy)sulfonyl]benzamide …
Matched Iupac: … N-(7-carbamimidoylnaphthalen-1-yl)-3-[(3-hydroxypropoxy)sulfonyl]benzamide …
4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL
Experimental
Matched Name: … 4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL …
Matched Iupac: … 4-(4-chlorophenyl)-1-{3-[2-(4-fluorophenyl)-1,3-dithiolan-2-yl]propyl}piperidin-4-ol …
Matched Iupac: … 4-(4-chlorophenyl)-1-{3-[2-(4-fluorophenyl)-1,3-dithiolan-2-yl]propyl}piperidin-4-ol …
3-(1-Aminoethyl)Nonanedioic Acid
Experimental
Matched Name: … 3-(1-Aminoethyl)Nonanedioic Acid …
Matched Iupac: … (3S)-3-[(1S)-1-aminoethyl]nonanedioic acid …
Matched Iupac: … (3S)-3-[(1S)-1-aminoethyl]nonanedioic acid …
(2S)-2-(1H-indol-3-yl)hexanoic acid
Experimental
Matched Name: … (2S)-2-(1H-indol-3-yl)hexanoic acid …
Matched Iupac: … (2S)-2-(1H-indol-3-yl)hexanoic acid …
Matched Iupac: … (2S)-2-(1H-indol-3-yl)hexanoic acid …
18-methyl-19-nortestosterone
Experimental
Illicit
Matched Synonyms: … 13beta-ethyl-17beta-hydroxygon-4-en-3-one …
Acetrizoic acid
Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid and it is the first monomeric ionic compound used as an X-ray contrast agent. It was first synthesized by Wallingford in 1953 and it was filled in the FDA by the Johnson & Johnson subsidiary, Cilag Chemie AG, on February 8th,...
Withdrawn
Matched Iupac: … 3-acetamido-2,4,6-triiodobenzoic acid …
Matched Description: … Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid[L1702] and it …
Matched Salts cas: … 129-63-5 …
Matched Description: … Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid[L1702] and it …
Matched Salts cas: … 129-63-5 …
Codeine methylbromide
Experimental
Illicit
Matched Iupac: … (1S,5R,13R,14S,17R)-14-hydroxy-10-methoxy-4,4-dimethyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17} …
Aspoxicillin
Experimental
Matched Iupac: … (2S,5R,6R)-6-[(2R)-2-[(2R)-2-amino-3-(methylcarbamoyl)propanamido]-2-(4-hydroxyphenyl)acetamido]-3,3- …
Displaying drugs 8051 - 8075 of 9934 in total